Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN81818883
ISRCTN81818883
Completed
未知

Double-blind, randomised, placebo-controlled pilot study of LC in systemic lupus erythematosus

Department of Health (Taiwan) - Executive Yuan0 sites90 target enrollmentApril 11, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSystemic lupus erythematosus (SLE)Musculoskeletal Diseases

Overview

Phase
未知
Intervention
Not specified
Conditions
Systemic lupus erythematosus (SLE)
Sponsor
Department of Health (Taiwan) - Executive Yuan
Enrollment
90
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 11, 2008
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Health (Taiwan) - Executive Yuan

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients fulfill the revised American College of Rheumatology (ACR) criteria for systemic lupus erythematosus (SLE)
  • •2\. Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI\-2K) score more than or equal to 2 and less than or equal to 36
  • •3\. Daily dose of prednisolone less than or equal to 0\.6 mg/kg
  • •4\. Age more than or equal to 7 years old and body weight more than or equal to 40 kg, either sex

Exclusion Criteria

  • •1\. Alcoholism
  • •2\. Diabetes mellitus
  • •3\. Life\-threatening disease
  • •4\. Pregnant or nursing women
  • •5\. Creatinine clearance less than or equal to 25 cc/min
  • •6\. Aspartate aminotransferase (AST), alanine aminotransferase (ALT) more than or equal to 2 x normal limit

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A pilot study of D-cycloserine-augmented cognitive behavioural therapy (CBT) with exposure therapy in adolescents with obsessive-compulsive disorder (OCD)Obsessive-compulsive disorderMental and Behavioural Disorders
ISRCTN70977225Institute of Psychiatry, Kings College London (UK)24
Active, not recruiting
Phase 1
A randomised double-blind placebo-controlled pilot study of D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorder
EUCTR2008-006947-38-GBKing's College London (Institute of Pyschiatry)24
Active, not recruiting
Phase 1
A pilot study of the use of metformin to reduce airway glucose in COPDChronic obstructive pulmonary diseaseMedDRA version: 21.1 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2018-001755-12-GBImperial College40
Active, not recruiting
Phase 1
Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (ASIA group) assesment who may respond to vardenafil treatment. - LEMDEErectile dysfunction (ED)
EUCTR2004-005282-37-ESQUIMICA FARMACEUTICA BAYER, S.A.
Completed
Not Applicable
A pilot randomized, double-blind, placebo-controlled, parallel-group clinical study to study the safety and tolerability of IP in healthy adults
CTRI/2023/03/050853Vedic Lifesciences Pvt Ltd64